---
figid: PMC11042538__MCO2-5-e542-g003
figtitle: 'Cellular senescence in cancer: molecular mechanisms and therapeutic targets'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11042538
filename: MCO2-5-e542-g003.jpg
figlink: /pmc/articles/PMC11042538/figure/mco2542-fig-0002/
number: F2
caption: Molecular features of senescent cells. Senescent cells undergo distinct chromatin
  changes including the formation of (A) γH2A.X, (B) senescence‐associated heterochromatin
  foci, and (C) the cytoplasmic chromatin fragments (CCFs). (D) Proteases such as
  MMPs, serine proteases, and controllers of plasminogen activation pathway are also
  secreted by senescent cells. (E) Senescent cells can also synthesize sEVs to remodel
  the TME. (F) Multiple upstream signals have been shown to regulate senescence features,
  and the majority of them eventually converge to activate CCAAT/enhancer‐binding
  protein β (C/EBP‐β) and nuclear factor kappa‐B (NF‐κB) signaling. HMGA, high mobility
  group protein A; HP1, heterochromatin protein 1; SAHF, senescence‐associated heterochromatin
  foci; CCFs, cytoplasmic chromatin fragments; ECM, extracellular matrix; uPA, serine
  proteases urokinase; tPA, tissue‐type plasminogen activators; MMPs, matrix metalloproteinases;
  ROS, reactive oxygen species; FN, fibronectin; sEVs, small extracellular vesicles.
papertitle: 'Cellular senescence in cancer: molecular mechanisms and therapeutic targets.'
reftext: Ping Jin, et al. MedComm (2020). 2024 May;5(5):e542.
year: '2024'
doi: 10.1002/mco2.542
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: John Wiley and Sons Inc.
keywords: immunosenescence | senescence | senescence‐associated secretory phenotype
  (SASP) | senotherapeutics | tumor
automl_pathway: 0.9576643
figid_alias: PMC11042538__F2
figtype: Figure
redirect_from: /figures/PMC11042538__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11042538__MCO2-5-e542-g003.html
  '@type': Dataset
  description: Molecular features of senescent cells. Senescent cells undergo distinct
    chromatin changes including the formation of (A) γH2A.X, (B) senescence‐associated
    heterochromatin foci, and (C) the cytoplasmic chromatin fragments (CCFs). (D)
    Proteases such as MMPs, serine proteases, and controllers of plasminogen activation
    pathway are also secreted by senescent cells. (E) Senescent cells can also synthesize
    sEVs to remodel the TME. (F) Multiple upstream signals have been shown to regulate
    senescence features, and the majority of them eventually converge to activate
    CCAAT/enhancer‐binding protein β (C/EBP‐β) and nuclear factor kappa‐B (NF‐κB)
    signaling. HMGA, high mobility group protein A; HP1, heterochromatin protein 1;
    SAHF, senescence‐associated heterochromatin foci; CCFs, cytoplasmic chromatin
    fragments; ECM, extracellular matrix; uPA, serine proteases urokinase; tPA, tissue‐type
    plasminogen activators; MMPs, matrix metalloproteinases; ROS, reactive oxygen
    species; FN, fibronectin; sEVs, small extracellular vesicles.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDR1
  - DDR2
  - ME3
  - PCDHGA5
  - ASF1A
  - HIRA
  - TP53
  - TP63
  - TP73
  - CDKN2A
  - ATM
  - DEFA1
  - CBX5
  - DEFA1B
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - RB1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MMP1
  - PLAU
  - PRAP1
  - MMP3
  - CGAS
  - PITX1
  - STING1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IRF3
  - TNF
  - IFNA1
  - IL6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - STAT3
  - JAK2
  - MTOR
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - GATA4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CEBPB
  - CXCL8
  - IL1A
  - ASPRV1
  - ROS
  - DNA
---
